Background: Endobronchial ultrasonography with a guide sheath (EBUS-GS) could be
Introduction
Lung cancer is a major health problem worldwide. The majority of patients are diagnosed with advanced and unresectable disease (stage IIIB/IV), which carries a 5-year survival rate of less than 5% [1] . Therefore, it is important to detect and treat lung cancer at an early stage.
Recently, due to advances in computed tomography (CT) and increased use of low-dose helical CT in lung cancer screening, small nodules, including solitary peripheral ground-glass opacity (GGO) predominant-type lesions, are being detected with greater frequency [2, 3] .
Furthermore, diagnosis of peripheral lung lesions has improved due to the introduction of endobronchial ultrasonography with a guide sheath (EBUS-GS) [4, 5] .
GGO is a finding on high-resolution CT (HRCT) that is defined as hazy increased attenuation of the lung with preservation of bronchial and vascular margins. In terms of radiologic characteristics, 2 types of GGO predominant type lesions can be identified: pure GGO is a lesion that has no solid component, while mixed GGO is a lesion that consists of heterogeneous attenuation with a solid component [6] [7] [8] . GGO predominant-type lesions on HRCT reflected a lepidic growth pattern of tumor cells microspically, related with presence of EGFR mutation and show slow growth over time [9] [10] . Therefore, patients with GGO predominat-type lesions have been reported to have a good prognosis [11] [12] [13] . However, several methodologic problems hinder diagnosis of GGO predominant-type lesions by transbronchial biopsy (TBB): (1) the lesions may not be visible under X-ray fluoroscopic 6 guidance; (2) there is difficulty in identifying accessible bronchial routes to reach peripheral lesions within the time limitation of the procedure; and (3) it is difficult to confirm whether biopsy forceps or a brush can accurately reach the lesions. We previously reported that EBUS-GS could be useful in clinical practice for diagnosing GGO predominant-type lesions in the peripheral lung [14, 15] , and recent studies have reported that some of these lesions are likely to be diagnosed as adenocarcinoma or precancerous lesions [14, [16] [17] [18] [19] .
Virtual bronchoscopic navigation (VBN) is a method in which virtual images of the bronchial path to a peripheral lesion are generated and used as a guide to navigate the bronchoscope [20, 21] . Several studies have reported that EBUS-GS with VBN was safe and effective for diagnosing small peripheral lung lesions [22, 23] . Furthermore, another study reported that diagnostic yield for small peripheral lung lesions is significantly increased when VBN is added to EBUS-GS [24] .
In the present study, we evaluated the diagnostic yield for GGO predominant-type lesions by TBB using EBUS-GS and VBN, and examined the clinical factors associated with diagnosis of such lesions.
Patients and Methods

Patients
The medical records of 169 patients with GGO predominant-type lesions who underwent TBB , and all patients provided written informed consent for TBB using EBUS-GS. In this study, GGO predominant-type lesions were defined as having a reduction of the maximum tumor area in the mediastinal window (Fig 1B, E) compared with the area in the lung window (Fig 1A, D) on thin-slice CT of ≥50% [25] . Among these lesions, pure GGO was defined as a lesion with no solid component (Fig 1A, B) , while mixed GGO was defined as a lesion with heterogeneous attenuation and any solid component (Fig 1D, E) . As to whether visible or invisible under X-ray fluoroscopy, we retrospectively confirmed GGO predominant-type lesions in X-ray films before bronchoscopy.
CT signs
CT signs of the lesions were retrospectively reviewed as has been previously reported [26] .
The relationship between the lesions and the bronchial or arterial trees was classified into 1 of 5 types according to their radiologic appearance on HRCT as follows: type 1, bronchus (with or without pulmonary artery) leading to the center of the lesion; type 2, bronchus (with or without pulmonary artery) leading to the edge of the lesion; type 3, pulmonary artery alone leading to the center of the lesion; type 4, pulmonary artery alone leading to the edge of the 8 lesion; and type 5, neither bronchus nor pulmonary artery leading to the lesion. According to these criteria, the medical records of 169 patients who underwent HRCT before TBB were retrospectively reviewed. In order to assess the relationship between the lesions and the bronchial or arterial trees, HRCT images were reviewed by 2 of 3 experienced pulmonologists.
When the decision concerning the bronchus-lesion or artery-lesion relationship by 2 of the pulmonologists was not compatible, the third pulmonologist made the final decision.
Virtual bronchoscopic navigation
All patients underwent chest CT to generate VB images to guide bronchoscopy. Based on chest CT data, a VBN system (Bf-Navi; Olympus Ltd, Tokyo, Japan; or DirectPath; Cybernet System Ltd, Tokyo, Japan) was used to detect the bronchial route to the target lesion and to produce the VBN. When the bronchus involved by the lesion was unclear, VB images of the bronchus closest to the lesion were produced.
TBB using EBUS-GS and Virtual bronchoscopic navigation
EBUS was performed using an endoscopic ultrasound system equipped with a 20-MHz mechanical radial-type probe (UM-S20-17R; Olympus Medical Systems, Tokyo, Japan) with an external diameter of 1.4 mm, or with an endoscopic ultrasound system equipped with a 20-MHz mechanical radial-type probe (UM-S20-20S; Olympus) with an external diameter of 9 1.7 mm. A flexible fiberoptic bronchoscope with a 2.0 mm diameter working channel (BF-P-260F; Olympus) and a guide sheath with an external diameter of 1.9 mm were used for the 1.4-mm probe, and a flexible fiberoptic bronchoscope with a <2.8 mm diameter working channel (BF-1T260; Olympus) and a guide sheath with an external diameter of 2.7 mm were used for the 1.7-mm probe. The bronchoscope was inserted as deeply as possible into the target bronchus under direct vision. An EBUS probe was inserted into the guide sheath, and the probe covered with the guide sheath was then inserted through the bronchoscope working channel and advanced to the GGO predominant-type lesions in order to obtain an EBUS image. EBUS imaging and X-ray fluoroscopy were used to confirm that the probe and guide sheath had reached the lesion. Until the lesions were visualized by EBUS-GS, TBB was assisted by using VBN to guide bronchoscopy. In mixed GGO predominant-type lesions, EBUS images showed one of the following: hyperechoic fine dots (<1 mm in diameter) or hyperechoic linear arcs (primarily around the probe) distributed irregularly within the lesions, or a hypoechoic nodule against the background of a delicate fine change in hypoechoic area with hyperechoic fine dots (Fig 1C) . On the other hand, in pure GGO predominant-type lesions, hyperechoic fine dots were slightly seen on EBUS images (Fig 1F) . After localizing the lesion using EBUS, the probe was removed to leave the guide sheath in the lesion.
Biopsy forceps and a bronchial brush were introduced via the guide sheath, and biopsy and brushing was performed under fluoroscopic guidance for pathologic and cytologic 10 examination. Biopsy was done six times and brushing three times as a routine.
Diagnosis
We did not use on-site cytology. An experienced pathologist interpreted each histologic and cytologic specimen. Suspicious findings were regarded as negative in our analysis. Final diagnosis was established according to pathologic evidence from biopsy including TBB or surgical procedures.
Statistical analysis
Data were analyzed by using Pearson's χ 2 test. Multivariate analysis was used to identify the factors affecting diagnostic yield. All variables reaching a significance level of 5% in univariate analysis were entered into logistic regression analysis. With regard to lesion size cutoff, we selected 20mm because of sensitivity analysis. Statistical software (Jump Pro 11.0.0; SAS Institute, Japan) was used for all analyses, with significance established at the P < 0.05 level.
Results
Diagnostic yield of TBB using EBUS-GS
In all 169 lesions, 31 were pure GGO predominant-type lesions and 138 were mixed GGO (Fig 2) . Two cases of pneumothorax occurred in association with this procedure.
Pathologic diagnosis
The pathologic diagnoses were adenocarcinoma in 114 lesions and inflammation in 2.
Ninety-nine lesions diagnosed as adenocarcinoma by TBB using EBUS-GS were resected surgically, 12 were irradiated, and the remaining 3 underwent clinical follow-up. 
Clinical factors associated with diagnostic yield
First, we analyzed the relationships between the characteristics of the lesions and diagnostic yield. When the size of diagnosed lesions was compared with that of nondiagnosed lesions, the former was significantly larger (22 mm vs. 18 mm, respectively; P < 0.01) ( (Table 3 ).
There was no GGO predominant-type lesion under 10 mm. Next, we analyzed the relationship between diagnostic yield and CT signs on HRCT. Lesions with a type 1 CT sign had significantly higher diagnostic yield than the other types (P < 0.01) ( Table 2 ). Finally, we analyzed the relationship between diagnostic yield and visibility of the lesion under X-ray fluoroscopy. When the lesions were confirmed under X-ray fluoroscopy, diagnostic yield was 76%; however, if confirmation was not possible, diagnostic yield decreased to 63% (P = 0.062) ( Table 2) .
Uni-and multivariate analyses of clinical factors affecting diagnostic yield
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In univariate analysis, lesion size (>20 mm) and CT sign (type 1) were found to be significant factors predicting diagnostic yield, while lesion visibility under X-ray fluoroscopy showed a tendency to predict diagnostic yield (Table 4) . In multivariate analysis, CT sign remained as the only significant factor predicting diagnostic yield (P < 0.01) ( Table 4) .
Comment
Although peripheral GGO predominant-type lesions are difficult to diagnose by bronchoscopy, there have been several reports demonstrating a promising diagnostic yield by TBB using EBUS-GS [14, 27] . This is the first study to demonstrate a promising diagnostic yield for peripheral GGO predominant-type lesions by TBB using EBUS-GS and VBN; of the 169 lesions included in the present study, 116 (69%) were successfully diagnosed by this method.
A surprising result was that 20 of 31 pure GGO predominant-type lesions could be successfully diagnosed.
We previously reported that EBUS-GS without VBN could be useful in clinical practice for diagnosing GGO predominant-type lesions in the peripheral lung, and described the advantages of EBUS-GS [14] . Especially, in the case of pure GGO, the change in brightness on EBUS images was very delicate when the EBUS probe was in and out of the lesions (Figure 1c) . However, after becoming familiar with the changes of the EBUS images, the positions of pure GGO can be confirmed and EBUS-GS become useful modality to 14 diagnose pure GGO predominant-type lesions. These advantages are also applicable to TBB using EBUS-GS and VBN. Compared with the results of our previous report, the addition of show that the addition of VBN to EBUS-GS could be more useful than EBUS-GS alone for obtaining EBUS images and diagnosing GGO predominant-type lesions.
In this study, we examined the relationships between the characteristics of the lesions and diagnostic yield by using uni-and multivariate analyses. In these analyses, CT sign was the most important factor. However, of 41 lesions with a CT sign of type 3 to 5 (type3, pulmonary artery alone leading to the center of the lesion; type4, pulmonary artery alone leading to the edge of the lesion; type5, neither bronchus nor pulmonary artery leading to the lesion), 37 (90%) were confirmed on EBUS-GS and 22 (54%) were successfully diagnosed.
Furthermore, of 61 diagnosed lesions that were not visible under X-ray fluoroscopy, 57 were considered to be "within image" or "adjacent to image" on EBUS. These results indicate that producing VBN to the bronchus that was central or closest to the lesion contributed to successfully reaching the lesion, obtaining EBUS-GS images of the lesion, and increasing diagnostic yield. 15 Lee et al reported that when pure GGO predominant-type lesions are greater than 15 mm in diameter with nodularity or harbor a solid component within them, the lesions are more likely to be invasive adenocarcinoma [28] . Furthermore, in this study, the rate of diagnosed malignancy was high and the diagnostic yield of lesions under 15mm was low (Table3). These suggest that we should not bronchospically approach all GGO predominant-type lesions. The patients who are low risk for an operation had better go directly to surgical resection if they are suspicious, <15mm pure GGO or mixed GGO predominant-type lesions and we should select and bronchospically approach GGO predominant-type lesions of the patients who were high risk for an operation when (1) In conclusion, the addition of VBN to EBUS-GS could be useful in clinical practice for diagnosing GGO predominant-type lesions in the peripheral lung. However, further prospective randomized studies are necessary to clarify its usefulness.
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